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A B S T R A C T
Prostate cancer is a major public health problem in all the developed countries. Increasing numbers of men with
nonmetastatic prostate cancer are receiving long-term androgen deprivation therapy (ADT). ADT is associated the loss of
bone mineral density and a increased risk of bone fractures. The standard recommendations for male bone health in-
clude above all optimizing calcium and vitamin D intake, and exercise. Vitamin D3 is an essential factor in the mainte-
nance of bone health and calcium homeostasis. The main supply of vitamin D3 is obtained through photosynthesis in the
skin. The aim of this study was to investigate the influence of insolation on osteoporosis progression in androgen de-
prived nonmetastatic prostate cancer patients. We divided our androgen deprived prostate cancer patients in 2 groups.
The first group (A) consists of 224 patients with insolation rate less then 3h per week. The second group (B) consists of
174 patients with insolation rate greater then 10h per week. With a questionnaire we determined, that patients from both
groups were 70 to 80 years old, body mass index was 25–30 kg/m2, androgen deprivation was 4–6 years and received no
vitamin D supplements. In the group A 21.86% suffered pathologic fractures do to osteoporosis. In the group B 10.92%
patients suffered from osteoporotic bone fractures. The risk for pathological bone fractures is significantly greater in the
group A. In conclusion higher insolation in androgen deprived nonmetastatic prostate cancer patients significantly de-
creases the osteoporosis progression and the risk of pathologic bone fractures.
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Introduction
Prostate cancer is a major public health problem fac-
ing man today in all the developed countries1. Prostate
cancer now outnumbers the lung cancer as the most
common cancer in American men1. The incidence of
prostate cancer is rapidly increasing in the Primorsko-
-Goranska County of Croatia1.
Increasing numbers of patients with nonmetastatic
prostate cancer are receiving long-term androgen depri-
vation therapy (ADT)2,3. ADT is associated with the loss
of bone mineral density and a significantly increased risk
of bone fractures in patients with prostate cancer2,4,5.
Male osteoporosis is an increasing health problem in
developed countries6. Almost one in four men older than
60 years of age will have an osteoporosis-related fractu-
re6. Androgen deprivation therapy, most commonly with
luteinizing hormone releasing hormone agonists or or-
chiectomy, increases the risk of male osteoporosis7.
Sex hormones, insulin-like growth factor 1, vitamin D
and calcium are essential for maintenance of bone helath8.
The standard recommendations for male bone health
include optimizing calcium and vitamin D intake, and
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exercise9. Vitamin D deficiency and insufficiency, hypo-
gonadism, glucocorticoids, and excess alcohol are the
most common causes of secondary bone loss in men10.
Vitamin D3 in human is mainly obtained through pho-
tosynthesis in the skin, and food ingestion contributes to
a small extent only11–17. So, sunlight is a necessary part
in the synthesis of cutaneous vitamin D12–17.
Materials and Methods
The study included 398 androgen deprived nonmeta-
static prostate cancer patients. Bone metastases were ex-
cluded by clinical staging. We divided our patients in two
groups. Group A consists of 224 patients with insolation
rate less then 3h per week. Group B consists of 174 pa-
tients with insolation rate greater then 10h per week.
Patients from both groups were 70–80 years old, body
mass index was 25–30 kg/m2, androgen deprivation dura-
tion was 4–6 years and received no vitamin D supple-
ments.
All above mentioned parameters were obtained from
a baseline questionnaire competed by the subjects. Os-
teoporotic bone fractures were detected by X-ray exami-
nation. Anamnestically we excluded severe traumatic in-
juries.
Statistical analysis
Conventional software, Statistica 6.1 (StatSoft, Inc.,
Tulsa, OK, USA) was used for standard statistical analy-
sis. p< 0.05 was considered statistically significant.
Results
In the group A (insolation rate <3 h/week) 49 (21.86%)
patients suffered pathologic fractures do to osteoporosis.
In the group B (insolation rate >10 h/week) 19 (10.92%)
patients suffered bone fractures do to osteoporosis (p<0.05,
Figure 1).
The difference in osteoporotic bone fractures rate be-
tween two groups is statistically significant (p<0.05).
The risk for pathologic fractures is significantly greater
in group A.
Discussion and Conclusion
Our results are clearly showing that the greater inso-
lation rate significantly decreases the risk of pathologic
bone fractures do to osteoporosis in androgen deprived
nonmetastatic prostate cancer patients.
As seen in previous studies, the prevention and man-
agement of osteoporosis in men receiving androgen de-
privation therapy, is an important issue of health care2,3.
Do to the constant increase of prostate cancer incidence
and number of men receiving long-term androgen depri-
vation therapy, the number of severe osteoporosis cases
is growing1–7,9,10.
Several new studies suggested that vitamin D supple-
ments and exercise can prevent severe osteoporosis in
men3,6,7. Others clamed that limiting alcohol consump-
tion, smoking cessation, optimizing calcium and vitamin
D intake, and exercise are crucial for male bone health4,5,9.
It has also been proved that vitamin D deficiency and in-
sufficiency contribute to secondary bone loss in men10–17.
It is well known that vitamin D3 is essential in the main-
tenance of healthy bone metabolism11–17. The main sup-
ply of vitamin D3 is obtained through photosynthesis in
the skin11–17.
Our results are consistent with above mentioned find-
ings. In the group A (insolation rate <3h/week) 21.86%
of patients suffered osteoporotic fractures, but in the
group B (insolation rate >10h/week) only 10.92% suf-
fered pathologic fractures. Also the risk for osteoporotic
fractures is significantly greater in the group A of andro-
gen deprived nonmetastatic prostate cancer patients.
The decreased rate of osteoporotic fractures in group B is
a consequence of greater insolation rate and vitamin D3
synthesis. Furthermore the greater insolation rate is
probably combined with greater physical activity rate per
week.
In conclusion greater exposure to the sun has multi-
ple positive effects on androgen deprived prostate cancer
patients and severe osteoporosis prevention.
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Fig. 1. Pathologic fractures rate (%) according to insolation rate
groups. Group A (insolation rate <3 h/week), and group B (inso-
lation rate >10 h/week).
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UTJECAJ INSOLACIJE NA NAPREDOVANJE OSTEOPOROZE U BOLESNIKA S NEMETASTATSKIM
KARCINOMOM PROSTATE POD ANDROGENOM DEPRIVACIJOM
S A @ E T A K
Karcinom prostate je vode}i javno-zdravstveni problem razvijenih zemalja. Raste broj bolesnika s nemetastatskim
karcinomom prostate, koji su na dugotrajnoj androgenoj deprivaciji. Androgena deprivacija povezana je sa smanjenjem
mineralne gusto}e kostiju i pove}anim rizikom od patolo{kih fraktura. Preporuke za o~uvanje ko{tanog zdravlja u
mu{karaca uklju~uju pove}anje unosa vitamina D, kalcija te fizi~ke aktivnosti. Vitamin D3 je nu`ni ~imbenik u o~uva-
nju ko{tanoga zdravlja i ravnote`e metabolizma kalcija. Glavni izvor vitamina D3 je fotosinteza u ko`i. Cilj ove studije
bio je istra`iti utjecaj insolacije na napredovanje osteoporoze u bolesnika s nemetastatskim karcinomom prostate pod
androgenom deprivacijom. Bolesnike pod androgenom deprivacijom podijelili smo u dvije grupe. Grupu A ~ine 224
bolesnika s vremenom insolacije manjim od 3h/tjedan. Grupu B ~ine 174 bolesnika s vremenom insolacije ve}im od
10h/tjedan. S anketnim upitnikom utvrdili smo kako su bolesnici u obje grupe stari izme|u 70 i 80 godina, indeks
tjelesne mase iznosio je 25–30 kg/m2, trajanje androgene deprivacije 4–6 godina te nisu uzimali nadomjesnu terapiju s
vitaminom D. U grupi A u 21,86% bolesnika dokazali smo osteoporoti~ne prijelome kostiju, a u grupi B u svega 10,92%.
Rizik pojavnosti patolo{kih fraktura kostiju bio je zna~ajno ve}i u grupi A. Zaklju~no dulja insolacija u bolesnika pod
androgenom deprivacijom zna~ajno smanjuje napredovanje osteoporoze i rizik od patolo{kih fraktura kostiju.
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